Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients

By Marshall Nicole   Ballman Karla   Michalak John   Schomberg Paula   Burton Gary   Sandler Howard   Cascino Terrence   Jaeckle Kurt   Buckner Jan  

Journal of Neuro-Oncology, Vol. 77, Iss. 3, 2006-05 ,pp. : 315-320

Springer Publishing Company

Access to resources Recommend Favorite

The Early Successful Treatment of Glioblastoma Patients with Modified boron Neutron Capture Therapy

By Kawabata Shinji   Miyatake Shin-Ichi   Kajimoto Yoshinaga   Kuroda Yuzo   Kuroiwa Toshihiko   Imahori Yoshio   Kirihata Mitsunori   Sakurai Yoshinori   Kobayashi Tohru   Ono Koji  

Journal of Neuro-Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 159-165

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of intensity-modulated radiotherapy with three-dimensional conformal radiation therapy planning for glioblastoma multiforme

By Chan M.F.   Schupak K.   Burman C.   Chui C.-S.   Ling C.C.  

Medical Dosimetry, Vol. 28, Iss. 4, 2003-12 ,pp. : 261-265

Elsevier

Access to resources Recommend Favorite

Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines

By Combs Stephanie   Bohl Jessica   Elsasser Thilo   Weber Klaus-Josef   Schulz-Ertner Daniela   Debus Jurgen   Weyrather Wilma  

International Journal of Radiation Biology, Vol. 85, Iss. 2, 2009-02 ,pp. : 126-137

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme

By Peereboom David   Shepard Dale   Ahluwalia Manmeet   Brewer Cathy   Agarwal Neeraj   Stevens Glen   Suh John   Toms Steven   Vogelbaum Michael   Weil Robert   Elson Paul   Barnett Gene  

Journal of Neuro-Oncology, Vol. 98, Iss. 1, 2010-05 ,pp. : 93-99

Springer Publishing Company

Access to resources Recommend Favorite